The clinical characteristics and prognosis of ABPA are closely related to the mucus plugs in central bronchiectasis
- PMID: 31758867
- PMCID: PMC7028037
- DOI: 10.1111/crj.13111
The clinical characteristics and prognosis of ABPA are closely related to the mucus plugs in central bronchiectasis
Abstract
Introduction: The characteristics of Allergic Bronchopulmonary Aspergillosis (ABPA) based on its radiological classification is still unclear.
Objectives: To investigate the clinical significances of ABPA patients with central bronchiectasis (ABPA-CB) by different radiological classifications of mucus plugs.
Methods: ABPA-CB patients from a pulmonary hospital between 2008 and 2015 were retrospectively included and analysed. According to the chest imaging in their first visit to physician, the ABPA-CB patients were divided into two groups based on the presence of high-attenuation mucus (HAM) or low-attenuation mucus (LAM). The primary endpoint was ABPA relapse within 1 year since the glucocorticoid withdrawal. The relationship between the imaging findings and the clinical prognosis was illuminated.
Results: A total of 125 ABPA patients were analysed in this study. Compared to the LAM group, the HAM group presented higher blood eosinophil cells counts, higher rates of Aspergillus detection isolated in sputum and expectoration of brownish-black mucus plugs, more affected lobes and segments, poorer pulmonary function and higher rate of relapse.
Conclusions: The clinical characteristics and prognosis of ABPA-CB patients are closely related to its radiological phenotype of mucus plugs in the central bronchiectasis. Clinicians should promote a diversity of personalized treatments for different patients with different radiological characteristics.
Keywords: allergic bronchopulmonary; aspergillosis; prognosis; radiology.
© 2019 The Authors. The Clinical Respiratory Journal published by John Wiley & Sons Ltd.
Conflict of interest statement
All the authors do not have any possible conflicts of interest.
Figures
References
-
- Agarwal R, Chakrabarti A. Allergic bronchopulmonary aspergillosis in asthma: epidemiological, clinical and therapeutic issues. Future Microbiol. 2013;8:1463‐1474. - PubMed
-
- Xu X, Xu J‐F, Zheng G, et al. CARD9S12N facilitates the production of IL‐5 by alveolar macrophages for the induction of type 2 immune responses. Nat Immunol. 2018;19:547‐560. - PubMed
-
- Greenberger PA. Allergic bronchopulmonary aspergillosis. J Allergy Clin Immunol. 2002;110:685‐692. - PubMed
-
- Agarwal R, Aggarwal AN, Gupta D, Jindal SK. Aspergillus hypersensitivity and allergic bronchopulmonary aspergillosis in patients with bronchial asthma: systematic review and meta‐analysis. Int J Tuberc Lung Dis. 2009;13:936‐944. - PubMed
-
- Chung KF, Wenzel SE, Brozek JL, et al. International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma. Eur Respir J. 2014;43:343‐373. - PubMed
